Odds ratio | 95% CI | p-value | |
---|---|---|---|
a. Major morbidity | |||
DA on POD1 ≥ 913 (U/l) | 2.89 | 0.573–2.51 | 0.63 |
CRP on POD1 ≥ 10.09 (mg/dl) | 2.45 | 1.1–5.47 | 0.028 |
DOV on POD3 ≥ 130 (ml) | 0.734 | 0.323–1.67 | 0.461 |
DA on POD3 ≥ 96 (U/l) | 2.89 | 1.46–5.73 | 0.002 |
WBC counts on POD3 ≥ 10,370 (/μl) | 1.38 | 0.605–3.160 | 0.443 |
CRP on POD3 ≥ 13.4 (mg/dl) | 3.25 | 1.38–7.68 | 0.007 |
b. IAI | |||
DOV on POD1 ≥ 380 (ml) | 0.602 | 0.328–1.110 | 0.102 |
DA on POD1 ≥ 608 (U/l) | 3.59 | 1.77–7.290 | < 0.001 |
CRP on POD1 ≥ 8.58 (mg/dl) | 1.77 | 1–3.13 | 0.048 |
DOV on POD3 ≥ 125 (ml) | 0.609 | 0.338–1.1 | 0.099 |
DA on POD3 ≥ 96 (U/l) | 1.38 | 0.692–2.73 | 0.363 |
WBC counts on POD3 ≥ 10,560 (/μl) | 1.46 | 0.8330–2.55 | 0.187 |
CRP on POD3 ≥ 13.95 (mg/dl) | 2.85 | 1.65–4.9 | < 0.001 |
c. CR-POPF | |||
DOV on POD1 ≥ 227 (ml) | 0.258 | 0.123–0.529 | < 0.001 |
DA on POD1 ≥ 2180 (U/l) | 6.8 | 3.24–14.3 | < 0.0001 |
CRP on POD1 ≥ 7.82 (mg/dl) | 2.04 | 0.822–5.06 | 0.124 |
DOV on POD3 ≥ 190 (ml) | 1.32 | 0.646–2.71 | 0.443 |
DA on POD3 ≥ 103 (U/l) | 3.56 | 1.4–9.09 | 0.008 |
WBC counts on POD3 ≥ 11,160 (/μl) | 1.59 | 0.769–3.27 | 0.211 |
CRP on POD3 ≥ 13.94 (mg/dl) | 3.41 | 1.68–6.95 | < 0.001 |
d. CR-CL | |||
DOV on POD1 ≥ 390 (ml) | 2.85 | 0.899–9.01 | 0.075 |
DOV on POD3 ≥ 332 (ml) | 5.36 | 1.56–18.4 | 0.008 |
CRP on POD3 ≥ 13.07 (mg/dl) | 0.361 | 0.0988–1.32 | 0.123 |
e. CR-PPH | |||
DOV on POD1 ≥ 206 (ml) | 0.432 | 0.186–1.00 | 0.051 |
DA on POD1 ≥ 457 (U/l) | 1.25 | 0.29–5.43 | 0.763 |
DA on POD3 ≥ 55 (U/l) | 6.01 | 0.59–61.2 | 0.13 |
WBC counts on POD3 ≥ 11,160 (/μl) | 2 | 0.85–4.67 | 0.111 |
CRP on POD3 ≥ 13.55 (mg/dl) | 11.6 | 2.61–51.6 | 0.001 |